| Literature DB >> 33284797 |
Ayumu Yamashita1, Yuki Sakai1, Takashi Yamada1,2, Noriaki Yahata1,3,4,5, Akira Kunimatsu6,7, Naohiro Okada3,8, Takashi Itahashi2, Ryuichiro Hashimoto1,2,9, Hiroto Mizuta10, Naho Ichikawa11, Masahiro Takamura11, Go Okada11, Hirotaka Yamagata12, Kenichiro Harada12, Koji Matsuo12,13, Saori C Tanaka1, Mitsuo Kawato1,14, Kiyoto Kasai1,3,8, Nobumasa Kato1,2, Hidehiko Takahashi10,15, Yasumasa Okamoto11, Okito Yamashita1,14, Hiroshi Imamizu1,16.
Abstract
Many studies have highlighted the difficulty inherent to the clinical application of fundamental neuroscience knowledge based on machine learning techniques. It is difficult to generalize machine learning brain markers to the data acquired from independent imaging sites, mainly due to large site differences in functional magnetic resonance imaging. We address the difficulty of finding a generalizable marker of major depressive disorder (MDD) that would distinguish patients from healthy controls based on resting-state functional connectivity patterns. For the discovery dataset with 713 participants from 4 imaging sites, we removed site differences using our recently developed harmonization method and developed a machine learning MDD classifier. The classifier achieved an approximately 70% generalization accuracy for an independent validation dataset with 521 participants from 5 different imaging sites. The successful generalization to a perfectly independent dataset acquired from multiple imaging sites is novel and ensures scientific reproducibility and clinical applicability.Entities:
Year: 2020 PMID: 33284797 DOI: 10.1371/journal.pbio.3000966
Source DB: PubMed Journal: PLoS Biol ISSN: 1544-9173 Impact factor: 8.029